Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-24

Clinical Trial Update: A Phase 3 Study to Evaluate Efficacy and Safety of HDM1002 Tablets in Adults With Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

This clinical trial update reports a Phase 3 study evaluating the efficacy and safety of HDM1002 tablets in adults with type 2 diabetes mellitus, currently recr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HDM1002 (HDM1002)

Snippet

Sponsor: Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | Conditions: Type 2 Diabetes | Phase 3 | Status: RECRUITING